HealthPhoto: Mint CompaniesZumutor Biologics Advances Cancer Drug Activating Natural Killer Cells
Zumutor Biologics is developing a novel cancer drug that activates natural killer cells. Its lead candidate is currently in phase 1 clinical trials. The startup aims to convert promising early clinical results into a licensing agreement and returns for investors, marking a significant step in cancer immunotherapy development.
Mint Companies·




